Publication

Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus

Downloadable Content

Persistent URL
Last modified
  • 08/15/2025
Type of Material
Authors
    Christopher M. Tipton, Emory UniversityChristopher F. Fucile, University of RochesterJamie Darce, Cell Signaling TechnolAsiya Chida, Emory UniversityTravis Ichikawa, Emory UniversityIvan Gregoretti, Cell Signaling TechnolSandra Schieferl, Cell Signaling TechnolJennifer R. Hom, Emory UniversityScott A. Jenks, Emory UniversityRon J. Feldman, Emory UniversityRamit Mehr, Bar Ilan UniversityChungwen Wei, Emory UniversityFrances Eun-Hyung Lee, Emory UniversityWan Cheung Cheung, Cell Signaling TechnolAlexander F. Rosenberg, University of RochesterIgnacio Sanz, Emory University
Language
  • English
Date
  • 2015-07-01
Publisher
  • Nature Publishing Group
Publication Version
Copyright Statement
  • © 2015, Springer Nature America, Inc.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1529-2908
Volume
  • 16
Issue
  • 7
Start Page
  • 755
End Page
  • +
Grant/Funding Information
  • Supported by grants U19 AI110483 (Autoimmunity Center of Excellence), 5P01AI078907, 5R37AI049660.
Supplemental Material (URL)
Abstract
  • Acute systemic lupus erythematosus (SLE) courses with surges of antibody-secreting cells (ASCs) whose origin, diversity and contribution to serum autoantibodies remain unknown. Here, deep sequencing, proteomic profiling of autoantibodies and single-cell analysis demonstrated highly diversified ASCs punctuated by clones expressing the variable heavy-chain region V<inf>H</inf>4-34 that produced dominant serum autoantibodies. A fraction of ASC clones contained autoantibodies without mutation, a finding consistent with differentiation outside the germinal centers. A substantial ASC segment was derived from a distinct subset of newly activated naive cells of considerable clonality that persisted in the circulation for several months. Thus, selection of SLE autoreactivities occurred during polyclonal activation, with prolonged recruitment of recently activated naive B cells. Our findings shed light on the pathogenesis of SLE, help explain the benefit of agents that target B cells and should facilitate the design of future therapies.
Author Notes
  • Correspondence should be addressed to I.S. Ignacio.sanz@emory.edu. current address: Biotherapeutic Technologies; Pfizer, Cambridge, MA, USA
Keywords

Tools

Relations

In Collection:

Items